Molecular Oncology,volume 12,issue 1  (01-2018)

Period of time： 2018年1期

Publisher： John Wiley & Sons Inc

Founded in： 2007

Total resources： 77

E-ISSN： 1878-0261|12|1

ISSN： 1574-7891

Subject： R Medicine and Health

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Molecular Oncology,volume 12,issue 1

Menu

Issue Information

Molecular Oncology,volume 12,issue 1 , Vol. 12, Iss. 1, 2018-01 , pp. 1-2

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Emerging functions of the EGFR in cancer

Molecular Oncology,volume 12,issue 1 , Vol. 12, Iss. 1, 2018-01 , pp. 3-20

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Expression of insulin‐like growth factor‐1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomes

Molecular Oncology,volume 12,issue 1 , Vol. 12, Iss. 1, 2018-01 , pp. 21-32

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

X‐linked inhibitor of apoptosis inhibition sensitizes acute myeloid leukemia cell response to TRAIL and chemotherapy through potentiated induction of proapoptotic machinery

Molecular Oncology,volume 12,issue 1 , Vol. 12, Iss. 1, 2018-01 , pp. 33-47

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patients

Molecular Oncology,volume 12,issue 1 , Vol. 12, Iss. 1, 2018-01 , pp. 48-57

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

A link between the fibroblast growth factor axis and the miR‐16 family reveals potential new treatment combinations in mesothelioma

Molecular Oncology,volume 12,issue 1 , Vol. 12, Iss. 1, 2018-01 , pp. 58-73

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Dabrafenib inhibits the growth of BRAF‐WT cancers through CDK16 and NEK9 inhibition

Molecular Oncology,volume 12,issue 1 , Vol. 12, Iss. 1, 2018-01 , pp. 74-88

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Tumor‐adjacent tissue co‐expression profile analysis reveals pro‐oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma

Molecular Oncology,volume 12,issue 1 , Vol. 12, Iss. 1, 2018-01 , pp. 89-113

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

miRNA profiling identifies deregulated miRNAs associated with osteosarcoma development and time to metastasis in two large cohorts

Molecular Oncology,volume 12,issue 1 , Vol. 12, Iss. 1, 2018-01 , pp. 114-131

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Characterization of genetic intratumor heterogeneity in colorectal cancer and matching patient‐derived spheroid cultures

Molecular Oncology,volume 12,issue 1 , Vol. 12, Iss. 1, 2018-01 , pp. 132-147

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Total 10 item(s)